Step by Stepa HemeOncBuddy patient portal

Isatuximab

Illustration: Isatuximab

Say it: eye-sa-TUX-i-mab · Brand names: Sarclisa, Sarclisa Escena

Isatuximab is an antibody medicine that marks myeloma cells so the immune system can destroy them.

What it is

Isatuximab is a lab-made antibody that sticks to a marker called CD38 on myeloma cells. This helps the immune system find and kill those cells and can also trigger the cancer cells to die. It is given with other myeloma medicines.

Often used for

How you get it

Isatuximab can be given into a vein (IV) at the clinic, or as a shot under the skin (Sarclisa Escena). The shot may be given by your nurse or by a small device stuck on your skin for a short time. The first vein infusion takes several hours, and later ones are often faster. It is usually given weekly for the first month, then every 2 weeks, and later sometimes every 4 weeks. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

Questions to ask

Part of these treatment plans

Side effect guides

Sources

Quick answers

What is Isatuximab?
Isatuximab is an antibody medicine that marks myeloma cells so the immune system can destroy them. Brand names: Sarclisa, Sarclisa Escena.
What is Isatuximab used for?
newly diagnosed multiple myeloma in people who are not having a stem cell transplant; multiple myeloma that has come back or stopped responding to other treatment.
How is Isatuximab given?
Isatuximab can be given into a vein (IV) at the clinic, or as a shot under the skin (Sarclisa Escena). The shot may be given by your nurse or by a small device stuck on your skin for a short time. The first vein infusion takes several hours, and later ones are often faster. It is usually given weekly for the first month, then every 2 weeks, and later sometimes every 4 weeks. Your schedule may be different.
What are the common side effects of Isatuximab?
Reactions during the infusion, like shortness of breath, cough, chills or nausea, most often with the first dose. Low blood counts, which can raise the risk of infection and bleeding. Lung infections or cold symptoms. Diarrhea. Feeling tired. Numbness or tingling in the hands or feet.
When should I call my care team while taking Isatuximab?
Trouble breathing, wheezing, throat tightness, or swelling of the face or lips; A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; Cough with fever or shortness of breath; Unusual bleeding or bruising; Chest pain or feeling faint.
Which chemotherapy plans include Isatuximab?
Isa-Pd.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.